shares of biotechnology company progenity inc are lower in thursdays latetrading session after the company said it plans to sell shares and warrants to purchase shares in an underwritten public offering at 510 pm et shares were trading 29 lower at 106 volume at the time topped 12 million shares the stock finished the days regulartrading session with a 69 loss closing at 149 progenity said it intends to use the net proceeds from this offering to support its operations invest in research and development with respect to its womens health diagnostic tests and its precision medicine platform and for working capital and general corporate purposes